Neus Salvatella

Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy

Antonio Colombo, Alaide Chieffo, Arian Frasheri et al. · Journal of the American College of Cardiology · 2014 · 423 citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +10

Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey

Piera Capranzano, Vijay Kunadian, Josepa Mauri et al. · EuroIntervention · 2016 · 71 citations

Medicine, Cardiology, Clinical Cardiology +7

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial

Rafael Romaguera, Pablo Salinas, Josep Gómez‐Lara et al. · European Heart Journal · 2021 · 46 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +11

Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study

Neus Salvatella, Marie‐Claude Morice, Olivier Darremont et al. · EuroIntervention · 2011 · 42 citations

Medicine, Cardiology, Surgery +17

Two-year outcomes of everolimus vs. paclitaxel-eluting stent for the treatment of unprotected left main lesions: a propensity score matching comparison of patients included in the French Left Main Taxus (FLM Taxus) and the LEft MAin Xience (LEMAX) registries

Anouska Moynagh, Neus Salvatella, Talal Harb et al. · EuroIntervention · 2013 · 34 citations

Medicine, Cardiology, Surgery +16